3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Polycythemia Vera
6
Thrombocythemia, Essential
5
Carcinoma, Hepatocellular
4
Neoplasms
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Philadelphia Chromosome
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Leukemia
2
Hepatitis C, Chronic
2
Carcinoma, Squamous Cell
2
Skin Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasm, Residual
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Influenza, Human
1
Infections
1
Hepatitis C
1
Hepatitis B, Chronic
1
Hemangiosarcoma
1
Colonic Neoplasms
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Brain Neoplasms
1
Blast Crisis
1
Interventions
Cyclophosphamide
59
Peripheral Blood Stem Cell Transplantation
51
fludarabine phosphate
47
Busulfan
39
Tacrolimus
38
Methotrexate
35
Mycophenolic Acid
31
Filgrastim
30
Cyclosporine
30
Cytarabine
29
Whole-Body Irradiation
28
Antilymphocyte Serum
28
Radiotherapy
22
Methylprednisolone
18
Etoposide
18
Melphalan
17
Cord Blood Stem Cell Transplantation
17
Imatinib Mesylate
13
Flow Cytometry
13
Thiotepa
11
Therapeutics
11
merphos
10
fludarabine
10
Granulocyte Colony-Stimulating Factor
10
Sirolimus
8
Rituximab
8
Psychiatric Rehabilitation
8
Prednisone
8
sargramostim
7
Dexamethasone
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Blast Crisis
×
peginterferon alfa-2a
×
Clear all
NCT00763763
2011-10-05
AFR07
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
55 enrolled